CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-748 Cr | ₹-591 Cr | ₹-403 Cr | ₹-293 Cr | ₹-205 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of CIPLA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-748 Cr |
| Mar2025 | ₹-591 Cr |
| Mar2024 | ₹-403 Cr |
| Mar2023 | ₹-293 Cr |
| Mar2022 | ₹-205 Cr |
How is Deferred Tax Assets / Liabilities of CIPLA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-748 Cr | Negative | |
| Mar2025 | ₹-591 Cr | Negative | |
| Mar2024 | ₹-403 Cr | Negative | |
| Mar2023 | ₹-293 Cr | Negative | |
| Mar2022 | ₹-205 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹116,440.3 Cr | 0.2% | 6.3% | -4.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,382.0 Cr | 0.8% | 7.3% | 15.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,375.0 Cr | 1.9% | 8.2% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,308.0 Cr | 0.6% | 12.6% | 43.9% | Stock Analytics | |
| MANKIND PHARMA | ₹105,979.0 Cr | 1.4% | 6.7% | -3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,106.0 Cr | -1.8% | -3.5% | -3.4% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 0.2% |
6.3% |
-4.5% |
| SENSEX | 0.1% |
0.7% |
-6.6% |
You may also like the below Video Courses